Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier W Sanders

Showing results (291-300 of 327) with videos related to

Pageof 33
Sort By:
Cell Reports|August 24, 2017
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by HyperstabilizationAlba Torrents de la Peña, Jean-Philippe Julien, Steven W de Taeye, et al.
Immunity|December 16, 2018
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody TitersMatthias G Pauthner, Joseph P Nkolola, Colin Havenar-Daughton, et al.
Nature Communications|September 21, 2019
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticlePhilip J M Brouwer, Aleksandar Antanasijevic, Zachary Berndsen, et al.
Immunity|April 29, 2014
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimersEmilia Falkowska, Khoa M Le, Alejandra Ramos, et al.
Cell Reports. Medicine|February 1, 2022
A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concernMarit J van Gils, Hugo D G van Willigen, Elke Wynberg, et al.
Nature Communications|August 11, 2021
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEMAleksandar Antanasijevic, Leigh M Sewall, Christopher A Cottrell, et al.
Cell|December 22, 2015
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesSteven W de Taeye, Gabriel Ozorowski, Alba Torrents de la Peña, et al.
Elife|November 23, 2021
Cross-reactive antibodies after SARS-CoV-2 infection and vaccinationMarloes Grobben, Karlijn van der Straten, Philip Jm Brouwer, et al.
Nature Communications|May 31, 2019
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequenceKwinten Sliepen, Byung Woo Han, Ilja Bontjer, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Pageof 33

Showing results (291-300 of 327) with videos related to

Sort By:
Pageof 33
Cell Reports|August 24, 2017
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by HyperstabilizationAlba Torrents de la Peña, Jean-Philippe Julien, Steven W de Taeye, et al.
Immunity|December 16, 2018
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody TitersMatthias G Pauthner, Joseph P Nkolola, Colin Havenar-Daughton, et al.
Nature Communications|September 21, 2019
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticlePhilip J M Brouwer, Aleksandar Antanasijevic, Zachary Berndsen, et al.
Immunity|April 29, 2014
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimersEmilia Falkowska, Khoa M Le, Alejandra Ramos, et al.
Cell Reports. Medicine|February 1, 2022
A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concernMarit J van Gils, Hugo D G van Willigen, Elke Wynberg, et al.
Nature Communications|August 11, 2021
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEMAleksandar Antanasijevic, Leigh M Sewall, Christopher A Cottrell, et al.
Cell|December 22, 2015
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesSteven W de Taeye, Gabriel Ozorowski, Alba Torrents de la Peña, et al.
Elife|November 23, 2021
Cross-reactive antibodies after SARS-CoV-2 infection and vaccinationMarloes Grobben, Karlijn van der Straten, Philip Jm Brouwer, et al.
Nature Communications|May 31, 2019
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequenceKwinten Sliepen, Byung Woo Han, Ilja Bontjer, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Pageof 33